| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 8 |
| 1 | ATEZOLIZUMAB | 6 |
| 2 | APIXABAN | 3 |
| 3 | FUROSEMIDE | 3 |
| 4 | ASPIRIN | 2 |
| 5 | CLOPIDOGREL | 2 |
| 6 | LENVATINIB | 2 |
| 7 | METOPROLOL TARTRATE | 2 |
| 8 | PANTOPRAZOLE | 2 |
| 9 | PANTOPRAZOLE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | 1 | 0.0015 |
| 1 | NITISINONE | 1 | 0.0010 |
| 2 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 1 | 0.0005 |
| 3 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 4 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 | 0.0003 |
| 5 | ATEZOLIZUMAB | 6 | 0.0002 |
| 6 | ROFLUMILAST | 1 | 0.0001 |
| 7 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0001 |
| 8 | CETIRIZINE HCL | 1 | 0.0001 |
| 9 | IRON SUCROSE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 1 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Pyridone [EPC] | 1 | 0.0000 |